choledocholithiasis
Conditions
Interventions
Experimental group:Chinese traditional medicine
control group:placebo
Sponsors
The Second Hospital of Shandong University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1) Patients with choledocholithiasis confirmed by enhanced CT or MRCP; 2) Age: 18-90 years old, gender is not limited; 3) No residual stones were confirmed by cholangiography after lithotomy/drainage; 4) In good general condition, Karnofsy score >= 60 points in the week before enrollment; 5) Patients diagnosed with Liver Depression and Qi Stagnation by traditional Chinese medicine or transformed into Liver Depression and Qi Stagnation syndrome after treatment; 6) Patients signed an informed consent to participate in the study and guaranteed follow-up.
Exclusion criteria
Exclusion criteria: 1) Previous (within 5 years) or concurrent malignant tumor; 2) Residual calculus after treatment; 3) Complicated gallstones and/or intrahepatic bile duct stones; 4) Patients with serious heart, lung and kidney diseases, cerebrovascular accidents and severe diabetic complications; 5) Pregnant or lactating patients; Patients with mental disorders; 6) People with allergic constitution or known allergy to the ingredients of this medicine; 7) Participating in other drug clinical trials or receiving other Chinese medicine treatment; 8) A history of severe malnutrition, infectious diseases and alcohol and drug addiction; 9) Irritable bowel syndrome and one-year inflammatory bowel disease; 10) Defective diseases of hearing, vision or movement disorders; 11) Other reasons considered by the investigator to be.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stone recurrence rate; | — |
Countries
China
Contacts
Public ContactYuliang Li
The Second Hospital of Shandong University
Outcome results
None listed